Two billion people still lack access to essential medicines, a gap shaped by underfunded health systems, weak manufacturing capacity, and discriminatory policies embedded within global supply chains
For individuals already taking Semaglutide Injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan with PlexusDx), allulose-sweetened foods offer a way to maintain sweet-food enjoyment without destabilizing blood glucose or undoing the appetite-suppressing benefits of GLP-1 therapy
In an upcoming hearing in May 2025, the judge overseeing these GLP-1 will decide what experts can speak at the test trials
[1] The mechanism of action centres on mimicking the naturally occurring hormone GLP-1, which is released from the intestine in response to food intake
Semaglutide works by mimicking the natural hormone GLP-1, which enhances insulin secretion in response to meals, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways